| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner
1 company
Jacinto Richard II is a 10% Owner at DiaMedica Therapeutics Inc.. Recent SEC Form 4 filings include 1 buy and 0 sells.
Estimated insider holdings value: $32.4M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 23, 2025 | DMAC Diamedica Therapeutics Inc. | 10% Owner | Buy | 400,000 | $3.50 | $1,400,000.00 | +8.8% | +28.5% | - |